Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation.
Clinical studies suggest that gut disorders are common in Parkinson's disease, but the morphological basis is unknown. Depletion of dopamine-containing neurons in the central nervous system is a basic defect in Parkinson's disease. We compared colonic tissue from 11 patients with advanced Parkinson's disease, 17 with adenocarcinoma (normal tissue was studied), and five who underwent colectomy for severe constipation. Immunohistochemistry was used to stain myenteric and submucosal neurons for dopamine, tyrosine hydroxylase, and vasoactive intestinal polypeptide (VIP). Each class of neurons was quantified as a percentage of the total neuronal population stained for the marker protein gene product 9.5. Nine of the 11 Parkinson's disease patients had substantially fewer dopaminergic myenteric neurons than the other subjects (mean 0.4 [SE 0.2] vs 6.9 [2.3] in controls and 5.7 [2.0] in constipated subjects). There was very little difference between the groups in numbers of tyrosine-hydroxylase and VIP neurons. Two Parkinson's disease patients had similar distributions of all types of neurons, including dopaminergic myenteric neurons, to the controls. High-performance liquid chromatography showed lower levels of dopamine in the muscularis externa (but not mucosa) in four Parkinson's disease patients than in four controls (7.3 [5.1] vs 24.2 [4.6] nmol per g protein), but levels of dopamine metabolites were similar in the two groups. The identification of this defect of dopaminergic neurons in the enteric nervous system in Parkinson's disease may lead to better treatment of colorectal dysfunction in this disease.
Singaram
C
C
Department of Internal Medicine, University of Wisconsin, Madison 52705, USA.
Ashraf
W
W
Gaumnitz
E A
EA
Torbey
C
C
Sengupta
A
A
Pfeiffer
R
R
Quigley
E M
EM
D000230:Adenocarcinoma / Q000473:pathology; D000368:Aged; D002908:Chronic Disease; D003082:Colectomy; D003106:Colon / Q000737:chemistry / Q000294:innervation* / Q000473:pathology; D003110:Colonic Neoplasms / Q000473:pathology; D003248:Constipation / Q000150:complications* / Q000378:metabolism / Q000473:pathology; D004298:Dopamine / Q000032:analysis* / Q000378:metabolism; D017615:Enteric Nervous System / Q000737:chemistry*; D006801:Humans; D008875:Middle Aged; D009474:Neurons / Q000737:chemistry*; D010300:Parkinson Disease / Q000150:complications* / Q000378:metabolism / Q000473:pathology; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism / Q000502:physiology
D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine